MedPath

Study of intermittent fasting to check whether it can cause weight loss improve liver function and quality of life and normalise blood pressure in fatty liver patients when compared to those not following intermittent fasting

Phase 2
Conditions
Health Condition 1: E660- Obesity due to excess calories
Registration Number
CTRI/2024/02/062783
Lead Sponsor
on funded study All India Institute of medical sciences jodhpur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Diagnosed case of metabolic syndrome and or Nonalcoholic fatty liver disease

Age between 18 and 75 years

Body mass index of greater than or equal to 25 kilogram per metre square

Exclusion Criteria

Pregnancy or lactation

Inherited or acquired immunodeficiency

On immunosuppressive drugs

On insulin or insulin secretagogues

Malignancies

Mental illness

Chronic kidney disease with estimated glomerular filtration rate eGFR less than or equal to30

Aspartate aminotransferase or Alanine transaminase more than three times the upper limit of normal

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
iver function tests at baseline and at 12 weeksTimepoint: Liver function tests at baseline and at 12 weeks
Secondary Outcome Measures
NameTimeMethod
<br/ ><br>weight loss in terms of Body Mass IndexTimepoint: At baseline and after 3 months;Fasting lipid profileTimepoint: At baseline and after 3 months;mean blood pressureTimepoint: At baseline and after 3 months;quality of life through a questionnaire of patients included in the study QOL will be assessed using the WHO BREF questionnaire.Timepoint: At baseline and after 3 months
© Copyright 2025. All Rights Reserved by MedPath